Status:
COMPLETED
Nutrition21 Study 1
Lead Sponsor:
Texas A&M University
Collaborating Sponsors:
Nutrition 21, Inc.
Conditions:
Nutritional Supplementation
Eligibility:
All Genders
18-40 years
Phase:
NA
Brief Summary
The purpose of this study is to determine the effects of nooLVL containing arginine and inositol supplementation on executive function and memory prior to and following playing video games.
Detailed Description
Gaming or "E-Sports" has become a very popular activity particularly among younger individuals. It requires quick reactions, executive function, memory and fine motor skill. In E-Sport competitions an...
Eligibility Criteria
Inclusion
- They are a healthy male or female Gamer 18 to 40 years of age;
- They have a Body Mass Index (BMI) between 18 and 34.9 kg/m2;
- They are willing to supply their own operator-oriented action or stragegy video game that they have played 21 times over the last 3 months and the gaming platform with all accessories needed to play the chosen game;
- They report no recent ingestion (\<2 weeks) of dietary supplements that affect cognitive function including nitrates and nitrous oxide (NO2) promoting supplements;
- They have a willingness to provide voluntary, written informed consent to participate in the study;
Exclusion
- They have known cardiovascular, metabolic and/or other diseases under the treatment of a physician requiring prescription (Rx) medication (birth control is allowed);
- They have a history of cognitive dysfunction;
- They have a known allergy to maltodextrin;
- They have known allergies or asthma;
- They have cirrhosis;
- They have guanidinoacetate methyltransferase deficiency;
- They have herpes;
- They have abnormally low blood pressure;
- They have had a recent heart attack (i.e., within one year);
- They have kidney disease;
- They have a surgery scheduled in the next 4-5 weeks;
- Thye have had a gastrectomy;
- They have a bipolar disorder;
- They have an allergy to aspirin or tartrazine products;
- They are pregnant or breast-feeding or plan to become pregnant in the next 4-5 weeks;
Key Trial Info
Start Date :
April 6 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2021
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT04828278
Start Date
April 6 2020
End Date
March 1 2021
Last Update
April 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Human Clinical Research Facility
College Station, Texas, United States, 77843